Average Co-Inventor Count = 4.20
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Eli Lilly and Company (28 from 4,442 patents)
2. Warner-lambert Company (2 from 2,538 patents)
3. Other (1 from 832,680 patents)
4. Eli Lilly Company (1 from 10 patents)
33 patents:
1. 12486249 - SSTR4 agonist salts
2. 12252491 - IL-17A inhibitors
3. 12071423 - Processes and intermediate for the large-scale preparation of 2,4,6-trifluoro-N-[6-(1-methyl-piperidine-4-carbonyl)-pyridin-2-yl]-benzamide hemisuccinate, and preparation of 2,4,6-trifluoro-N-[6-(1-methyl-piperidine-4-carbonyl)-pyridin-2-yl]-benzamide acetate
4. 11999722 - Disubstituted pyrazole compounds
5. 11834435 - SSTR4 agonist salts
6. 11827618 - Processes and intermediate for the large-scale preparation of 2,4,6-trifluoro-n-[6-(1-methyl-piperidine-4-carbonyl)-pyridin-2-yl]-benzamide hemisuccinate, and preparation of 2,4,6-trifluoro-n-[6-(1-methyl-piperidine-4-carbonyl)-pyridin-2-yl]-benzamide acetate
7. 11746115 - Solid forms of 7-[[(1S)-1-[4-[(1S)-2-cyclopropyl-1-(4-prop-2-enoylpiperazin-1-yl)ethyl]phenyl]ethyl]amino]-1-ethyl-4H-pyrimido[4,5-d][1,3]oxazin-2-one
8. 11655242 - Glucagon-like peptide1 receptor agonists
9. 11498915 - TrkA Inhibitor
10. 11124500 - Disubstituted pyrazole compounds
11. 11066386 - CGRP receptor antagonists
12. 10968214 - KRas G12C inhibitors
13. 10934280 - Condensed thiophene derivatives useful as NaPi-IIb inhibitors
14. 10793552 - Amino pyrimidine ssao inhibitors
15. 10787460 - (E)-1-(4-(dimethylamino)but-2-enoyl)pyrrolidin-3-yl 4-((3-isopropyl-5-methylpyrazolo[1,5-a]pyrimidin-7-yl)amino)piperidine-1-carboxylate for inhibiting CDK7